Extended Low-Dose Valganciclovir Is Effective Prophylaxis Against Cytomegalovirus in High-Risk Kidney Transplant Recipients With Near-Complete Eradication of Late-Onset Disease
Fayek, S.A, Beshears, E, Lieber, R, Alvey, N, Sauer, A, Poirier, J, Hollinger, E.F, Olaitan, O.K, Jensik, S, Geyston, J, Brokhof, M.M, Hodowanec, A.C, Hertl, M, Simon, D.M
Published in Transplantation proceedings (01.07.2016)
Published in Transplantation proceedings (01.07.2016)
Get full text
Journal Article